2026-05-29 Shionogi & Co.,Ltd. “Regarding the approval of naldemedine, a treatment for opioid-induced constipation, as a new drug in China.”
2026-05-29 Shionogi & Co.,Ltd. “Regarding the approval of naldemedine, a treatment for opioid-induc … 続きを読む
Shionogi & Co.,Ltd.
2026-05-26 Shionogi & Co.,Ltd. “We have posted the "Notice of Convocation of the 161st Ordinary General Meeting of Shareholders."”
2026-05-26 Shionogi & Co.,Ltd. “We have posted the "Notice of Convocation of the 161st Ordinar … 続きを読む
2026-05-26 Shionogi & Co.,Ltd. “We have posted a notice of partial correction to the Notice of Convocation of the 161st Ordinary General Meeting of Shareholders.”
2026-05-26 Shionogi & Co.,Ltd. “We have posted a notice of partial correction to the Notice of Conv … 続きを読む
2026-05-19 Shionogi & Co.,Ltd. “Regarding the positive interim analysis results of the domestic Phase III clinical trial of the aromatic hydrocarbon receptor (AhR) modulator "Tapinarov Cream 0.5%" in infants and young children with atopic dermatitis.”
2026-05-19 Shionogi & Co.,Ltd. “Regarding the positive interim analysis results of the domestic Pha … 続きを読む
2026-05-15 Shionogi & Co.,Ltd. “We have posted the transcript of the FY2025 financial results briefing.”
2026-05-15 Shionogi & Co.,Ltd. “We have posted the transcript of the FY2025 financial results brief … 続きを読む
2026-05-14 Shionogi & Co.,Ltd. “The results of the global Phase 3 post-exposure prevention trial (SCORPIO-PEP trial) of the anti-coronavirus (SARS-CoV-2) drug encitrelvir fumarate have been published in The New England Journal of Medicine.”
2026-05-14 Shionogi & Co.,Ltd. “The results of the global Phase 3 post-exposure prevention trial (S … 続きを読む
2026-05-12 Shionogi & Co.,Ltd. “We have posted the financial results presentation materials for fiscal year 2025.”
2026-05-12 Shionogi & Co.,Ltd. “We have posted the financial results presentation materials for fis … 続きを読む
2026-05-12 Shionogi & Co.,Ltd. “We have posted our financial results summary and supplementary materials for fiscal year 2025.”
2026-05-12 Shionogi & Co.,Ltd. “We have posted our financial results summary and supplementary mate … 続きを読む
2026-04-28 Shionogi & Co.,Ltd. “Regarding our participation in the World Economic Forum and our signing of the Davos Compact on AMR: Contributing to the resolution of global healthcare challenges, including AMR, through global collaboration.”
2026-04-28 Shionogi & Co.,Ltd. “Regarding our participation in the World Economic Forum and our sig … 続きを読む
2026-04-27 Shionogi & Co.,Ltd. “Notice Regarding Revision of Dividend Forecast (Increase in Dividend) for the Fiscal Year Ending March 2026.”
2026-04-27 Shionogi & Co.,Ltd. “Notice Regarding Revision of Dividend Forecast (Increase in Dividen … 続きを読む